Cardiovascular Risks and Urinary Albumin Excretion(UAE) in Polycystic Ovarian Syndrome (PCO)
NCT02569164 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50
Last updated 2015-10-06
Summary
PCO patients will be assessed clinically,urine \& blood samples will be tested. Systolic \& diastolic blood pressure, serum glucose \& insulin levels, lipid profile, C-reactive protein, complete hormonal profile, and Urinary albumin excretion will be measured.
Conditions
- Urinary Albumin Excretion
Sponsors & Collaborators
-
Kasr El Aini Hospital
lead OTHER
Principal Investigators
-
suzy abdelaziz, M.D. · kasrelaini
Eligibility
- Min Age
- 20 Years
- Max Age
- 50 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2015-11-30
- Completion
- 2015-12-31
More Related Trials
-
Correlation of Insulin Resistance With Hormonal and Ovarian Morphological Characteristics in Patients With Polycystic Ovarian Syndrome
NCT05661565 ·Status: UNKNOWN
-
Serum Ghrelin in Polycystic Ovary Syndrome
NCT02087410 ·Status: UNKNOWN
-
Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome
NCT00005459 ·Status: COMPLETED
-
Study of Metabolism and Cardiovascular Disease(CVD) in Women With Polycystic Ovary Syndrome (PCOS)
NCT01117558 ·Status: COMPLETED
-
PolyCystic Ovary Syndrome as Suggested Risk Group for Non-Alcoholic Fatty Liver Disease
NCT07146815 ·Status: COMPLETED ·Phase: NA
-
Expression of CVD and HA Between Obesity and Non-obesity Polycystic Ovary Syndrome (PCOS) Women in Taiwan
NCT01113918 ·Status: COMPLETED
-
Cardiovascular Risk Markers in Polycystic Ovary Syndrome (PCOS)
NCT01195168 ·Status: COMPLETED
-
Serum Preptin and Amylin Levels in Polycystic Ovary Syndrome Patients
NCT03587415 ·Status: COMPLETED
-
Serum Fetuin Level in Polycystic Ovary Syndrome
NCT03819998 ·Status: UNKNOWN
-
To Study Polycystic Ovary Syndrome in Taiwanese Women
NCT01256944 ·Status: COMPLETED
-
Serum Metabolomics Study of Polycystic Ovary Syndrome
NCT03618342 ·Status: UNKNOWN
-
Impact of 11-oxygenated Androgens on Metabolic Dysfunction of Women With Polycystic Ovary Syndrome
NCT05246865 ·Status: UNKNOWN ·Phase: NA
-
The Frequency of Polycystic Ovary Syndrome Among Young Reproductive Females Presenting With Hyperandrogenism: a Mixed Cohort Study
NCT05734287 ·Status: RECRUITING
-
Mean Platelet Volume and TXA2 Levels in Patients With Polycystic Ovary Syndrome (PCOS)
NCT01538602 ·Status: COMPLETED
-
Evaluation of Endocrine and Metabolic Parameters in the New Diagnostic Phenotypes of Polycystic Ovary Syndrome
NCT00784615 ·Status: UNKNOWN
-
Metabolic Differences Between Subtypes of Polycystic Ovary Syndrome
NCT06342180 ·Status: COMPLETED
-
PCOS, Therapy and Markers of Cardiovascular Risk
NCT01798875 ·Status: UNKNOWN ·Phase: PHASE4
-
The Role of Autoimmunity and Obesity in Polycystic Ovary Syndrome
NCT05929950 ·Status: UNKNOWN
-
DAISy-PCOS Phenome Study - Dissecting Androgen Excess and Metabolic Dysfunction in Polycystic Ovary Syndrome
NCT03911297 ·Status: RECRUITING
-
Molecular Basis of PCOS in Oocytes and Surrounding Cells
NCT04493788 ·Status: UNKNOWN
-
Oral Contraceptive and Cardiovascular Risk in PCOS
NCT00593294 ·Status: COMPLETED ·Phase: PHASE4
-
Endocrine and Menstrual Disturbances in Women With Polycystic Ovary Syndrome (PCOS)
NCT03652987 ·Status: SUSPENDED
-
Biomechanical Changes in Females with Poly Cystic Ovarian Syndrome
NCT06673901 ·Status: COMPLETED
-
Evaluation of Serum Scube-1 Scube-2 and Scube-3 Levels in Patients With Polikistik Over Syndrome ,
NCT03765905 ·Status: COMPLETED
-
Detection of PCOS by Sensors Array
NCT03046537 ·Status: UNKNOWN ·Phase: NA